[Preparations for treatment of hypoparathyreoidism (antitetanics). 36].
D000085:Acetates / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D002122:Calcium Chloride / Q000627:therapeutic use; D002130:Calcium Phosphates / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D002951:Citrates / Q000627:therapeutic use; D004097:Dihydrotachysterol / Q000627:therapeutic use; D004872:Ergocalciferols / Q000627:therapeutic use; D005942:Gluconates / Q000627:therapeutic use; D006801:Humans; D007011:Hypoparathyroidism / Q000188:drug therapy*; D007773:Lactates / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D010281:Parathyroid Hormone / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D013885:Thiosulfates / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D000085:Acetates; D002130:Calcium Phosphates; D002951:Citrates; D004872:Ergocalciferols; D005942:Gluconates; D007773:Lactates; D010281:Parathyroid Hormone; D012459:Salicylates; D013885:Thiosulfates; D014807:Vitamin D; D002762:Cholecalciferol; D008274:Magnesium; D002122:Calcium Chloride; D004097:Dihydrotachysterol; D011188:Potassium; D002118:Calcium
Präparate zur Behandlung des Hypoparathyreoidismus (Antitetanika). 36.